$Tharimmune (THAR.US)$Tharimmune Announces Results In Phase 1 Clinical Trial Of TH104, Compared Oral Transmucosal Delivery Of TH104 To Injectable Reference Approved Drug Completed Benzinga· 4 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
MangoXoXo : What happened with the news?? It dropped
Trytosaveabit OP MangoXoXo : Yup! PM and AM are hard to trade! You don’t get a clear picture of interest and liquidity! GL
SIAwinner : no good. trap buyer. many rush to buy. all trap.